Mixed Treatment Comparison Meta-Analysis of Aspirin, Warfarin, and New Anticoagulants for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation

医学 阿哌沙班 依杜沙班 拜瑞妥 达比加群 华法林 阿司匹林 冲程(发动机) 心房颤动 内科学 麻醉 随机对照试验 机械工程 工程类
作者
Abdullah M. Assiri,Omar Al-Majzoub,Abir O. Kanaan,Jennifer L. Donovan,Matthew J. Silva
出处
期刊:Clinical Therapeutics [Elsevier BV]
卷期号:35 (7): 967-984.e2 被引量:40
标识
DOI:10.1016/j.clinthera.2013.05.011
摘要

Warfarin and aspirin are used to prevent stroke in patients with atrial fibrillation (AF). There are inherent challenges with both treatments, including variable and inconsistent benefit and increased bleeding risks. The availability of new anticoagulants offers some alternatives.A mixed treatment comparison meta-analysis to evaluate direct and indirect treatment data including aspirin, warfarin apixaban, dabigatran, edoxaban, and rivaroxaban for the prevention of primary or secondary stroke in patients with AF.A comprehensive, systematic literature search was conducted to identify randomized trials comparing aspirin, warfarin, apixaban, dabigatran, edoxaban, and rivaroxaban in patients with AF requiring treatment for stroke prevention. Open-label and blinded designs were included if they evaluated any stroke or any bleeding event. Data on stroke and bleeding events were abstracted, verified, evaluated, scored, and entered into Aggregate Data Drug Information System version 1.16 to generate a mixed treatment comparison meta-analysis. Direct and indirect comparisons were evaluated, and we looked for inconsistency in closed loop structures. Data are reported as rate ratios with 95% credible intervals. In addition, we reviewed variance statistics and explored variance with node-splitting models.Our literature search yielded 30 articles, 21 of which were included. All treatments except aspirin reduced the risk of any stroke compared with placebo. Warfarin (0.43 [0.33-0.57]), apixaban (0.37 [0.27-0.54]), dabigatran (0.34 [0.21-0.57]), rivaroxaban (0.36 [0.22-0.60]), and aspirin with clopidogrel (0.73 [0.53-0.99]) were more protective than aspirin alone. Warfarin and the new anticoagulants were similar in the reduction of stroke, vascular death, and mortality. There was no difference in major bleeding between any treatment group. There were more nonmajor bleeding events when comparing warfarin and apixaban (1.83 [1.05-4.03]); no other differences between warfarin and the other new anticoagulants were found.This mixed treatment comparison meta-analysis found similarity between warfarin and the new anticoagulants with the exception of one comparison, in which warfarin was associated with more non-major bleeding than apixaban. Thus, the new anticoagulants are therapeutically comparable when warfarin is inappropriate.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
冬瓜鑫发布了新的文献求助10
1秒前
1秒前
知白守黑完成签到,获得积分10
2秒前
斯文败类的应助被codwest采纳,获得10
2秒前
柒柒完成签到 ,获得积分10
2秒前
2秒前
2秒前
3秒前
哈47发布了新的文献求助10
3秒前
彩虹桥发布了新的文献求助10
3秒前
3秒前
4秒前
4秒前
anna1992发布了新的文献求助10
4秒前
4秒前
4秒前
4秒前
赘婿的应助被jingjing采纳,获得10
4秒前
5秒前
Unless发布了新的文献求助10
5秒前
SciGPT的应助被风趣青槐采纳,获得10
5秒前
李爱国的应助被WATQ采纳,获得10
5秒前
郑睿涛发布了新的文献求助10
6秒前
Laoma发布了新的文献求助10
6秒前
神宝嘎li完成签到,获得积分0
7秒前
yao发布了新的文献求助10
7秒前
小旋风完成签到,获得积分10
7秒前
Ma发布了新的文献求助10
7秒前
DuMilk完成签到,获得积分10
7秒前
有魅力的雨梅完成签到,获得积分10
8秒前
小王发布了新的文献求助10
8秒前
鸭梨发布了新的文献求助10
8秒前
yhuyfuhk完成签到 ,获得积分10
8秒前
呆萌发布了新的文献求助10
8秒前
田様的应助被Mxr采纳,获得10
9秒前
9秒前
董亦菲发布了新的文献求助10
9秒前
猫好好发布了新的文献求助10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183091
求助须知:如何正确求助?哪些是违规求助? 9572406
关于积分的说明 21825003
捐赠科研通 7779812
什么是DOI,文献DOI怎么找? 3433837
关于科研通互助平台的介绍 2558045
邀请新用户注册赠送积分活动 2480046